Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 87

    1.

    Germline polymorphisms in SIPA1 are associated with metastasis and other indicators of poor prognosis in breast cancer.

    Crawford NP, Ziogas A, Peel DJ, Hess J, Anton-Culver H, Hunter KW.

    Breast Cancer Res. 2006;8(2):R16. Epub 2006 Mar 21.

    PMID:
    16563182
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.

    Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.

    BMC Cancer. 2009 Sep 18;9:331.

    PMID:
    19765277
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.

    Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW.

    Breast Cancer Res. 2009;11(5):R75. Epub .

    PMID:
    19825179
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Germline polymorphisms are potential metastasis risk and prognosis markers in breast cancer.

    Hsieh SM, Lintell NA, Hunter KW.

    Breast Dis. 2006-2007;26:157-62. Review.

    PMID:
    17473374
    [PubMed - indexed for MEDLINE]
    5.

    Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis.

    Gaudet MM, Hunter K, Pharoah P, Dunning AM, Driver K, Lissowska J, Sherman M, Peplonska B, Brinton LA, Chanock S, Garcia-Closas M.

    Int J Cancer. 2009 Apr 1;124(7):1716-20.

    PMID:
    19089925
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

    Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS.

    Gynecol Oncol. 2010 Mar;116(3):539-43. Epub 2009 Nov 10.

    PMID:
    19906411
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Germline RAP80 mutations and susceptibility to breast cancer.

    Akbari MR, Ghadirian P, Robidoux A, Foumani M, Sun Y, Royer R, Zandvakili I, Lynch H, Narod SA.

    Breast Cancer Res Treat. 2009 Jan;113(2):377-81. Epub 2008 Feb 28.

    PMID:
    18306035
    [PubMed - indexed for MEDLINE]
    8.

    Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent.

    Cavallone L, Arcand SL, Maugard C, Ghadirian P, Mes-Masson AM, Provencher D, Tonin PN.

    BMC Cancer. 2008 Apr 10;8:96.

    PMID:
    18402691
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1.

    Park YG, Zhao X, Lesueur F, Lowy DR, Lancaster M, Pharoah P, Qian X, Hunter KW.

    Nat Genet. 2005 Oct;37(10):1055-62. Epub 2005 Sep 4.

    PMID:
    16142231
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Contribution of germline BRCA1 and BRCA2 sequence alterations to breast cancer in Northern India.

    Saxena S, Chakraborty A, Kaushal M, Kotwal S, Bhatanager D, Mohil RS, Chintamani C, Aggarwal AK, Sharma VK, Sharma PC, Lenoir G, Goldgar DE, Szabo CI.

    BMC Med Genet. 2006 Oct 4;7:75.

    PMID:
    17018160
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Matrix metalloproteinase single-nucleotide polymorphisms and haplotypes predict breast cancer progression.

    Hughes S, Agbaje O, Bowen RL, Holliday DL, Shaw JA, Duffy S, Jones JL.

    Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6673-80.

    PMID:
    18006768
    [PubMed - indexed for MEDLINE]
    Free Article
    12.

    Association of matrix metalloproteinase-8 gene variation with breast cancer prognosis.

    Decock J, Long JR, Laxton RC, Shu XO, Hodgkinson C, Hendrickx W, Pearce EG, Gao YT, Pereira AC, Paridaens R, Zheng W, Ye S.

    Cancer Res. 2007 Nov 1;67(21):10214-21.

    PMID:
    17974962
    [PubMed - indexed for MEDLINE]
    Free Article
    13.

    Common germline genetic variation in antioxidant defense genes and survival after diagnosis of breast cancer.

    Udler M, Maia AT, Cebrian A, Brown C, Greenberg D, Shah M, Caldas C, Dunning A, Easton D, Ponder B, Pharoah P.

    J Clin Oncol. 2007 Jul 20;25(21):3015-23.

    PMID:
    17634480
    [PubMed - indexed for MEDLINE]
    14.

    Rrp1b, a new candidate susceptibility gene for breast cancer progression and metastasis.

    Crawford NP, Qian X, Ziogas A, Papageorge AG, Boersma BJ, Walker RC, Lukes L, Rowe WL, Zhang J, Ambs S, Lowy DR, Anton-Culver H, Hunter KW.

    PLoS Genet. 2007 Nov;3(11):e214. Epub 2007 Oct 16.

    PMID:
    18081427
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Promoter polymorphisms in matrix metalloproteinases and their inhibitors: few associations with breast cancer susceptibility and progression.

    Lei H, Hemminki K, Altieri A, Johansson R, Enquist K, Hallmans G, Lenner P, Försti A.

    Breast Cancer Res Treat. 2007 May;103(1):61-9. Epub 2006 Oct 11.

    PMID:
    17033924
    [PubMed - indexed for MEDLINE]
    16.

    A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.

    Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ, Huang W, Shao ZM.

    J Cancer Res Clin Oncol. 2007 Dec;133(12):969-78. Epub 2007 Jun 12.

    PMID:
    17562079
    [PubMed - indexed for MEDLINE]
    17.

    Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility: a case-control analysis.

    Huo X, Hu Z, Zhai X, Wang Y, Wang S, Wang X, Qin J, Chen W, Jin G, Liu J, Gao J, Wei Q, Wang X, Shen H.

    Breast Cancer Res Treat. 2007 May;102(3):329-37. Epub 2006 Sep 21.

    PMID:
    17028982
    [PubMed - indexed for MEDLINE]
    18.

    Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.

    Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J.

    BMC Cancer. 2006 Sep 29;6:230.

    PMID:
    17010193
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    The BARD1 Cys557Ser variant and breast cancer risk in Iceland.

    Stacey SN, Sulem P, Johannsson OT, Helgason A, Gudmundsson J, Kostic JP, Kristjansson K, Jonsdottir T, Sigurdsson H, Hrafnkelsson J, Johannsson J, Sveinsson T, Myrdal G, Grimsson HN, Bergthorsson JT, Amundadottir LT, Gulcher JR, Thorsteinsdottir U, Kong A, Stefansson K.

    PLoS Med. 2006 Jul;3(7):e217.

    PMID:
    16768547
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Host genetic variants in the interleukin-6 promoter predict poor outcome in patients with estrogen receptor-positive, node-positive breast cancer.

    DeMichele A, Gray R, Horn M, Chen J, Aplenc R, Vaughan WP, Tallman MS.

    Cancer Res. 2009 May 15;69(10):4184-91. Epub 2009 May 12.

    PMID:
    19435922
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk